Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Aseffa

Showing results (191-200 of 399) with videos related to

Pageof 40
Sort By:
Frontiers in Pharmacology|May 12, 2020
Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer PatientsJemal Hussien Ahmed, Eyasu Makonnen, Ronald Kuteesa Bisaso, et al.
The American Journal of Pathology|May 14, 2009
Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesionsSayma Rahman, Berhanu Gudetta, Joshua Fink, et al.
Nutrients|February 1, 2019
Vitamin D Status and Association of <i>VDR</i> Genetic Polymorphism to Risk of Breast Cancer in EthiopiaJemal Hussien Ahmed, Eyasu Makonnen, Alan Fotoohi, et al.
Clinical & Developmental Immunology|January 22, 2011
Modulation of cell death by M. tuberculosis as a strategy for pathogen survivalMarkos Abebe, Louise Kim, Graham Rook, et al.
Journal of Infection in Developing Countries|September 19, 2009
Identification and genotyping of the etiological agent of tuberculous lymphadenitis in EthiopiaDemissew Beyene, Indra Bergval, Elena Hailu, et al.
Cytokine|September 21, 2020
Enhanced production of pro-inflammatory cytokines and chemokines in Ethiopian cutaneous leishmaniasis upon exposure to Leishmania aethiopicaMenberework Chanyalew, Markos Abebe, Birtukan Endale, et al.
Wellcome Open Research|March 26, 2026
Rapid Ethical Appraisal: A tool to design a contextualized consent process for a genetic study of podoconiosis in EthiopiaTewodros Tariku Gebresilase, Zebene Deresse, Girmay Tsegay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2Abebech Demissie, Markos Abebe, Abraham Aseffa, et al.
Plos One|April 20, 2019
Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysisDaniel Mekonnen, Awoke Derbie, Andargachew Abeje, et al.
Tropical Diseases, Travel Medicine and Vaccines|December 12, 2018
Line-probe assay and molecular typing reveal a potential drug resistant clone of <i>Mycobacterium tuberculosis</i> in EthiopiaShiferaw Bekele, Yohannes Derese, Elena Hailu, et al.
Pageof 40

Showing results (191-200 of 399) with videos related to

Sort By:
Pageof 40
Frontiers in Pharmacology|May 12, 2020
Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer PatientsJemal Hussien Ahmed, Eyasu Makonnen, Ronald Kuteesa Bisaso, et al.
The American Journal of Pathology|May 14, 2009
Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesionsSayma Rahman, Berhanu Gudetta, Joshua Fink, et al.
Nutrients|February 1, 2019
Vitamin D Status and Association of <i>VDR</i> Genetic Polymorphism to Risk of Breast Cancer in EthiopiaJemal Hussien Ahmed, Eyasu Makonnen, Alan Fotoohi, et al.
Clinical & Developmental Immunology|January 22, 2011
Modulation of cell death by M. tuberculosis as a strategy for pathogen survivalMarkos Abebe, Louise Kim, Graham Rook, et al.
Journal of Infection in Developing Countries|September 19, 2009
Identification and genotyping of the etiological agent of tuberculous lymphadenitis in EthiopiaDemissew Beyene, Indra Bergval, Elena Hailu, et al.
Cytokine|September 21, 2020
Enhanced production of pro-inflammatory cytokines and chemokines in Ethiopian cutaneous leishmaniasis upon exposure to Leishmania aethiopicaMenberework Chanyalew, Markos Abebe, Birtukan Endale, et al.
Wellcome Open Research|March 26, 2026
Rapid Ethical Appraisal: A tool to design a contextualized consent process for a genetic study of podoconiosis in EthiopiaTewodros Tariku Gebresilase, Zebene Deresse, Girmay Tsegay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2Abebech Demissie, Markos Abebe, Abraham Aseffa, et al.
Plos One|April 20, 2019
Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysisDaniel Mekonnen, Awoke Derbie, Andargachew Abeje, et al.
Tropical Diseases, Travel Medicine and Vaccines|December 12, 2018
Line-probe assay and molecular typing reveal a potential drug resistant clone of <i>Mycobacterium tuberculosis</i> in EthiopiaShiferaw Bekele, Yohannes Derese, Elena Hailu, et al.
Pageof 40